How a skin medication helps people with moderate-to-severe psoriasis in Canada

This is a real-world study that follows people with moderate-to-severe psoriasis who are starting treatment with tildrakizumab, a medication designed to help control psoriasis. The study will track how well the medication works, how safe it is, and most importantly, how it affects your daily life and quality of life over the course of one year. The research is being done across Canada to make sure the results reflect the experiences of Canada's diverse population.

Although this medication has been approved in Canada since 2018, doctors and researchers still don't have much real-world information about how it works for Canadian patients—especially for people with darker skin tones. This study aims to fill that gap and make sure the treatment is truly working well for everyone.